GenMark Diagnostics Just Filed Its Quarterly Report: The following table ...


The following table summarizes the Company’s marketable securities as of June 30, 2014 and December 31, 2013 (in thousands):
June 30, 2014
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Value
Corporate notes and bonds
 
$
26,669

 
$
6

 
$
(23
)
 
$
26,652

U.S. government and agency securities
 
33,417

 
9

 
(6
)
 
33,420

Commercial paper
 
2,498

 

 

 
2,498

Total
 
$
62,584

 
$
15

 
$
(29
)
 
$
62,570

 
 
 
 
 
 
 
 
 
December 31, 2013
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Value
Corporate notes and bonds
 
$
22,949

 
$
12

 
$
(7
)
 
$
22,954

U.S. government and agency securities
 
43,124

 
3

 
(12
)
 
43,115

Commercial paper
 
3,797

 

 

 
3,797

Total
 
$
69,870


$
15

 
$
(19
)
 
$
69,866

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. GenMark Diagnostics next reports earnings on August 11, 2014.

To receive a free e-mail notification whenever GenMark Diagnostics makes a similar move, sign up!

Other recent filings from the company include the following:

GenMark Diagnostics just filed a General Statement of acquisition of beneficial ownership - Jan. 14, 2015
Current report, items 1.01, 2.02, 2.03, and 9.01 - Jan. 12, 2015
GenMark Diagnostics's President and CEO just disposed of 4,858 shares - Jan. 9, 2015

   Auto Refresh

Feedback